Laborie Medical Technologies Acquires UroMed Technology

Laborie Medical Technologies Inc., a portfolio company of Audax Group (“Audax”), has completed the acquisition of UroMed Technology, Inc.’s pelvic muscle rehabilitation business.

Headquartered in San Ramon, Calif., UroMed develops biofeedback and electrical stimulation medical equipment and accessories, and consumables for pelvic floor rehabilitation in the treatment of urinary and fecal incontinence. The acquisition of UroMed expands Laborie’s offering in pelvic muscle rehabilitation and in the conservative therapy sector, executives said.

Based in Toronto, Ontario, Laborie is a global manufacturer and supplier of medical testing equipment and consumables, supplying physician offices, hospitals, and mobile providers on six continents. Since Audax’s acquisition in July 2012, Laborie also has completed the acquisition of Life-Tech Inc., based in Stafford, Texas, in January of 2013.

Young Lee, managing director of Audax Group, said “Laborie is a market leader in global pelvic health. We will continue to work with Brian Ellacott and the Laborie team to grow the business through organic growth opportunities and strategic add-on acquisitions.”

Laborie CEO Brian Ellacott added, “The acquisition of UroMed is an exciting development for Laborie. In combining our product lines, we will now be able to deliver better products and services to our customers, while maintaining the standards of support that they have come to expect.”

Audax Group, founded in 1999, invests in lower-middle market companies. With offices in Boston and New York, Audax has more than $5 billion in assets under management in its private equity, mezzanine, and senior debt businesses.